Medtronic Plc Financial Diagnostics

<div class='circular--portrait' style='background:#8A0CCF;color: white;font-size:4em;padding-top: 15px;;'>ME</div>
MDT -- USA Stock  

USD 119.03  0.17  0.14%

The latest bullish price patterns experienced by current Medtronic plc shareholders may encourage investors to take a closer look at the firm as it closed today at a share price of 118.56 on 4696237.000 in trading volume. The company executives have been very successful with rebalancing the firm assets at opportune times to take advantage of market volatility in December. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 0.818. The very small Stock volatility is a good signal to investors with longer term investment horizons. This diagnostics interface makes it easy to digest most current publicly released information about Medtronic Plc as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Medtronic Plc price relationship with some important fundamental indicators such as market cap and management efficiency. Additionally see Stocks Correlation.

Medtronic Plc Note

About 85.0% of the company shares are owned by institutional investors. The book value of Medtronic Plc was now reported as 22.24. The company has Price/Earnings To Growth (PEG) ratio of 2.79. Medtronic plc last dividend was issued on 2019-12-26. The entity had 2:1 split on 1999-09-27. Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. Medtronic Plc operates under Medical Devices classification in USA and is traded on BATS Exchange. It employs 90000 people. To find out more about MEDTRONIC INC contact Omar Ishrak at 353 1 438 1700 or learn more at http://www.medtronic.com.

Medtronic plc Alerts

Over 85.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Richard Anderson of 3305 shares of Medtronic Plc subject to Rule 16b-3

Medtronic plc Upcoming and Recent Events

Upcoming Quarterly Earning ReportFebruary 18, 2020
Next Earnings ReportMay 28, 2020
Next Fiscal Quarter EndJanuary 31, 2020
Next Fiscal Year EndMay 28, 2020
Last Quarter Report DateOctober 31, 2019
Last Earning Anouncement DateJanuary 31, 2019

Medtronic Plc Earning Estimates

EPSEstimate Date
Quarterly Estimate1.38February 18, 2020
Medtronic plc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Medtronic Plc SEC Filings

Submission of Matters to a Vote of Security Holders
Results of Operations and Financial Condition
Regulation FD Disclosure
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Results of Operations and Financial Condition
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure. Entry into a Material Definitive Agreement
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure

Medtronic Plc Thematic Classifications

Obamacare Repeal IdeaObamacare Repeal
Large healthcare related equities associated with Obamacare
Giant Impact IdeaGiant Impact
Public companies with mega capitalization
Medical Equipment IdeaMedical Equipment
USA Equities from Medical Equipment industry as classified by Fama & French

Market Capitalization

The company currently falls under 'Mega-Cap' category with total capitalization of 148.71 B.

Stock Holders for Medtronic Plc

Information
Ratio
Value
At Risk
Nasdaq Yewno Global Innovative 0.06 (0.90) 
Nasdaq Yewno Global Disruptive 0.32 (0.21) 
NYSE 0.0169 (0.98) 
Nasdaq Victory US 500 Large Vol(0.0373) (0.97) 
Nasdaq Victory US 500 Large Vol(0.06) (0.75) 
Nasdaq Victory US 500 Large Vol(0.06) (0.75) 
Nasdaq US Large Cap Value NTR I(0.0127) (0.73) 
Nasdaq US Contrarian Value Net(0.06) (1.19) 
NASDAQ US Large Mid Cap Index 0.0236 (1.14) 
Nasdaq CTA Artificial Intellige 0.05 (1.01) 
Nasdaq CTA Artificial Intellige 0.05 (1.01) 
NASDAQ N America Large Mid Cap(0.0049) (0.87) 
Nasdaq US Mega Cap Select Leade 0.21 (0.90) 
Nasdaq Dorsey Wright Peoples Po(0.017) (0.96) 
Nasdaq Singularity Net Total Re 0.05 (1.15) 
Nasdaq Singularity Index 0.0391 (1.13) 
NASDAQ US Dividend Achievers Se(0.06) (1.19) 
Vanguard Wellington Fund Admira(0.13) (0.67) 
Virtus Vontobel Greater Europea(0.14) (1.04) 
MFS Global Equity Fund Class A(0.0244) (0.64) 

Technical Drivers

As of the 21th of January Medtronic Plc secures Mean Deviation of 0.6517, Risk Adjusted Performance of 0.0871 and Downside Deviation of 0.9032. In connection with Fundamental Indicators, Macroaxis technical analysis interface lets you check existing technical drivers of Medtronic plc as well as the relationship between them. Strictly speaking you can use this information to find out if the firm will indeed mirror its model of past prices or the prices will eventually revert. We found nineteen technical drivers for Medtronic Plc which can be compared to its peers in the industry. Please verify Medtronic plc Variance as well as the relationship between Value At Risk and Skewness to decide if Medtronic plc is priced some-what accurately providing market reflects its recent price of 119.03 per share. Given that Medtronic plc has Jensen Alpha of 0.1275, we recommend you check Medtronic Plc last-minute market performance to make sure the company can sustain itself at future point.

Medtronic plc Price Movement Analysis

The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Kaufman Adaptive Moving Average allows the user to define Medtronic plc range across which they want the smoothing. View also all equity analysis or get more info about kaufman adaptive moving average overlap studies indicator.

Medtronic plc Insider Trading Activities

Medtronic Plc Outstanding Bonds

MaturityCouponRating
585055AH9 4.75%09/15/20154.75
AA-
585055AN6 5.6%03/15/20195.6
AA-
585055AQ9 6.5%03/15/20396.5
AA-
585055AR7 3.0%03/15/20153.0
AA-
585055AS5 4.45%03/15/20204.45
AA-
585055AT3 5.55%03/15/20405.55
AA-
585055AU0 2.625%03/15/20162.625
AA-
585055AV8 4.125%03/15/20214.125
AA-
585055AW6 4.5%03/15/20424.5
AA-
585055AX4 3.125%03/15/20223.125
AA-
585055AY2 4.0%04/01/20434.0
AA-
585055AZ9 2.75%04/01/20232.75
AA-
585055BA3 1.375%04/01/20181.375
AA-
585055BB1 0.875%02/27/20170.875
AA-
585055BC9 3.625%03/15/20243.625
AA-
585055BD7 4.625%03/15/20444.625
AA-

Medtronic Plc Technical and Predictive Indicators

Medtronic Plc Forecast Models

Recommendations

Medtronic plc Analyst Recommendations

Target PriceAdvice# of Analysts
121.71Buy21Odds
Medtronic plc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Medtronic Plc Analyst Advice  

Vital Value Indicators

Medtronic Plc Basic Pricing Drivers

Quick Ratio2.02
Fifty Two Week Low82.77
Trailing Annual Dividend Rate2.08
Revenue Growth3.00%
Payout Ratio60.29%
Shares Short Prior Month12.08M
Average Daily Volume Last 10 Day4.28M
Average Daily Volume In Three Month4.12M
Earnings Growth23.20%
Shares Percent Shares Out0.74%
Gross Margins69.61%
Earnings Quarterly Growth22.30%
Short Percent Of Float0.74%
Forward Price Earnings19.71
Float Shares1.34B
Fifty Two Week High119.84
Enterprise Value To Ebitda18.60
Fifty Day Average114.26
Two Hundred Day Average108.01
Trailing Annual Dividend Yield1.75%
Enterprise Value To Revenue5.70
Additionally see Stocks Correlation. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Company logos by clearbit